Drugs for Motion Sickness (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 41)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Diphenhydramine |
Approved, Investigational |
Phase 4 |
|
147-24-0, 58-73-1 |
3100 |
Synonyms:
147-24-0
147-24-0 (HYDROCHLORIDE)
2-(benzhydryloxy)-N,N-dimethylethylamine
2-(Benzhydryloxy)-N,N-dimethylethylamine
2-(Benzhydryloxy)-N,N-dimethylethylamine, hydrochloride
2-(diphenylmethoxy)-N,N-dimethylethanamine
2-(Diphenylmethoxy)-N,N-dimethylethylamine
2-[(diphenylmethyl)oxy]-N,N-dimethylethanamine
2-benzhydryloxyethyl-N,N-dimethylammonium
2-benzhydryloxy-N,N-dimethylethanamine
2-diphenylmethoxy-N,N-demthylethanamine
2-Diphenylmethoxy-N,N-demthylethanamine
2-Diphenylmethoxy-N,N-dimethylethylamine
2PM
58-73-1
88637-37-0 (citrate (1:1))
a-(2-Dimethylaminoethoxy)diphenylmethane
AB00053460
AC-13704
AC1L1F65
AKOS003658554
Aleryl
Alledryl
Allerdryl
Allergan
Allergan B
Allergeval
Allergical
Allergina
Allergival
Allermax Caplets
Aller-Med
alpha-(2-Dimethylaminoethoxy)diphenylmethane
Amidryl
Antistominum
Antitussive
Antomin
Automin
Bagodryl
Banophen
Banophen Caplets
Baramine
b-Dimethylaminoethanol diphenylmethyl ether
b-Dimethylaminoethyl benzhydryl ether
Beldin
Belix
Bena
Benachlor
Benadrin
Benadryl
Benadryl (hydrochloride)
Benadryl Allergy
BENADRYL HCl
Ben-allergin
Benapon
Bendylate
Benhydramin
Benodin
Benodine
Benylan
Benylin
Benzantin
Benzantine
Benzhydramine
Benzhydraminum
Benzhydril
Benzhydroamina
Benzhydryl
beta-Dimethylamino-aethyl-benzhydryl-aether
beta-Dimethylamino-aethyl-benzhydryl-aether [German]
beta-Dimethylaminoethanol diphenylmethyl ether
beta-dimethylaminoethyl benzhydryl ether
beta-Dimethylaminoethyl benzhydryl ether
beta-Dimethylaminoethylbenzhydrylether
Betramin
BIDD:GT0152
BPBio1_000275
BRD-K47278471-003-05-7
BRN 1914136
BSPBio_000249
BSPBio_002219
CAS-147-24-0
CCRIS 1959
CHEBI:127629
CHEBI:4636
CHEMBL657
CID3100
Citrate, diphenhydramine
Compoz
CPD-10890
D00300
Dabylen
DB01075
DB06975
Debendrin
Dermistina
Dermodrin
Desentol
Diabenyl
Diabylen
Dibendrin
Dibenil
Dibondrin
Difedryl
Difenhidramina
Difenhidramina [INN-Spanish]
Difenhydramin
Difenhydramine
Difenidramina
Difenidramina [Italian]
Dihidral
Dimedrol
Dimedrol base
Dimedrolum
Dimedryl
Dimehydrinate
Dimethylamine benzhydryl ester
|
Diphamine
Diphantine
Diphen
Diphen Cough
Diphenhist
Diphenhist Captabs
diphenhydramine
Diphenhydramine
Diphenhydramine (JP15/INN)
Diphenhydramine [INN:BAN:JAN]
Diphenhydramine Base
Diphenhydramine citrate
Diphenhydramine citrate (1:1)
Diphenhydramine HCl
Diphenhydramine hydrochloride
DIPHENHYDRAMINE, ANTISTOMINUM, BENZHYDRAMINE
Diphenhydraminum
Diphenhydraminum [INN-Latin]
Diphenylhydramin
Diphenylhydramine
DivK1c_000368
Dobacen
Dormarex 2
Dormin
Dryistan
Drylistan
Dylamon
EINECS 200-396-7
Etanautine
FAR 90X2
Genahist
Histaxin
HMS2089E06
HSDB 3066
Hyadrine
Hydramine
Hydrochloride, diphenhydramine
Hyrexin
I14-6749
Ibiodral
IDI1_000368
KBio1_000368
KBio2_001460
KBio2_004028
KBio2_006596
KBio3_001439
KBioGR_001099
KBioSS_001460
L000227
Lopac0_000377
Lopac-D-3630
LS-68208
Medidryl
Mephadryl
MLS002222276
MolPort-001-783-508
N-(2-(diphenylmethoxy)ethyl)-N,N-dimethylamine
N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine
N-(Benzhydryloksy-etylo)dwumetyloamina
N-(Benzhydryloksy-etylo)dwumetyloamina [Polish]
N,N-Dimethyl-2-(diphenylmethoxy)-ethylamine hydrochloride
N-[2-(BENZHYDRYLOXY)ETHYL]-N,N-DIMETHYLAMINE
Nausen
NCGC00015335-01
NCGC00015335-02
NCGC00015335-03
NCGC00015335-10
NCGC00024414-03
NCGC00024414-04
nchembio747-comp18
NCI60_002916
NCI60_022782
Nervine Nighttime Sleep-Aid
NINDS_000368
Novamina
NSC665800
Nytol Quickcaps
Nytol Quickgels
O-benzhydryldimethylaminoethanol
O-Benzhydryldimethylaminoethanol
Oprea1_254625
PM 255
Prestwick0_000065
Prestwick1_000065
Prestwick2_000065
Prestwick3_000065
Probedryl
Restamin
Restamin (TN)
Rigidil
S51
Siladryl
Silphen
Sleep-Eze D
Sleep-Eze D Extra Strength
SMR001307259
SPBio_000961
SPBio_002170
Spectrum_000980
Spectrum2_000961
Spectrum3_000400
Spectrum4_000520
Spectrum5_000915
STK103720
STOCK2S-94461
Syntedril
Syntodril
TL8003758
Twilite Caplets
UNII-8GTS82S83M
Unisom Sleepgels Maximum Strength
α-(2-dimethylaminoethoxy)diphenylmethane
Α-(2-dimethylaminoethoxy)diphenylmethane
β-dimethylaminoethanol diphenylmethyl ether
Î’-dimethylaminoethanol diphenylmethyl ether
β-dimethylaminoethyl benzhydryl ether
Î’-dimethylaminoethyl benzhydryl ether
|
|
2 |
|
Promethazine |
Approved, Investigational |
Phase 4 |
|
60-87-7 |
4927 |
Synonyms:
(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine
(2-Dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine
(Dimethylamino-2-propyl-10-phenothiazine hydrochloride
10-(2-(Dimethylamino)-2-methylethyl)phenothiazine
10-(2-(Dimethylamino)propyl)phenothiazine
10-(2-Dimethylaminopropyl)phenothiazine
10-[2-(dimethylamino)propyl]phenothiazine
10-[2-(Dimethylamino)propyl]phenothiazine
10H-Phenothiazine-10-ethanamine, N,N,alpha-trimethyl- (9CI)
10H-Phenothiazine-10-ethanamine, N,N,alpha-trimethyl-, radical ion(1+)
3277 RP
3389 R.p.
38878-40-9
4182 R.p.
4-27-00-01253 (Beilstein Handbook Reference)
60-87-7
73745-50-3
A-91033
AB00053535
AC-15939
AC1L1J92
Antiallersin
Aprobit
Atosil
Avomine
BPBio1_000744
BRN 0088554
BSPBio_000676
BSPBio_002777
C07404
Camergan
CCRIS 7056
CHEBI:8461
CHEMBL643
CID4927
D00494
DB01069
Dimapp
Dimethylamino-isopropyl-phenthiazin
Dimethylamino-isopropyl-phenthiazin [German]
Diphergan
Diprazin
Diprazine
Diprozin
DivK1c_000005
EINECS 200-489-2
Fargan
Fenazil
Fenetazina
Fenetazine
Genphen
Hiberna
Histargan
HMS2089E08
HSDB 3173
Hydrochloride, promethazine
IDI1_000005
Iergigan
InChI=1/C17H20N2S/c1-13(18(2)3)12-19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19/h4-11,13H,12H2,1-3H3
Isophenergan
Isopromethazine
KBio1_000005
KBio2_001348
KBio2_003916
KBio2_006484
KBio3_001997
KBioGR_001697
KBioSS_001348
L000495
Lercigan
Lergigan
Lilly 01516
Lilly 1516
Lopac0_000899
LS-264
Metaryl
MolPort-001-783-684
N-(2'-dimethylamino-2'-methyl)ethylphenothiazine
N-(2'-Dimethylamino-2'-methyl)ethylphenothiazine
N,N,alpha-trimethyl-10H-phenothiazine-10-ethanamine
N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine
N,N,a-Trimethyl-10H-phenothiazine-10-ethanamine
N,N,α-trimethyl-10H-phenothiazine-10-ethanamine
N,N,Α-trimethyl-10H-phenothiazine-10-ethanamine
N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine
|
N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine
N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine hydrochloride
NCGC00015817-10
NCGC00089735-02
NCGC00089735-03
NCI60_001878
NCI-C60673
N-Dimethylamino-2-methylethyl thiodiphenylamine
NINDS_000005
NSC 30321
NSC30321
Oprea1_758749
Pelpica
Phargan
Phenargan
Phenergan
Phenerzine
Phenoject-50
Phensedyl
Pilothia
Pilpophen
Pipolfen
Pipolphen
Pipolphene
Prestwick0_000888
Prestwick1_000888
Prestwick2_000888
Prestwick3_000888
Pro-50
Proazaimine
Proazamine
Procit
Promacot
Promazinamide
Promergan
Promesan
Promet
Prometasin
Prometazin
Prometazina
Prometazina [INN-Spanish]
Prometazine
Prometh
Promethacon
Promethaine
Promethazin
promethazine
Promethazine
Promethazine (JAN/INN)
PROMETHAZINE (SEE ALSO PROMETHAZINE HYDROCHLORIDE 58-33-3)
Promethazine [INN:BAN]
Promethazine hydrochloride
PromethazineHcl
Promethazinum
Promethazinum [INN-Latin]
Promethegan
Promethiazine
Promezathine
Prorex
Protazine
Prothazin
Prothazine
Provigan
Pyrethia
Pyrethiazine
Remsed
Romergan
RP 3277
Rumergan
SKF 1498
SPBio_000799
SPBio_002895
Spectrum_000868
Spectrum2_000840
Spectrum3_001019
Spectrum4_001149
Spectrum5_000977
Tanidil
Thiergan
UNII-FF28EJQ494
Valergine
Vallergine
WLN: T C666 BN ISJ B1Y1&N1&1
WY 509
Zipan-25
|
|
3 |
|
Ginger |
Approved |
Phase 4 |
|
|
|
4 |
|
Histamine |
Approved, Investigational |
Phase 4 |
|
51-45-6, 75614-87-8 |
774 |
Synonyms:
.beta.-Imidazolyl-4-ethylamine
[3H]histamine
1avn
1H-Imidazole-4-ethanamine
1H-Imidazole-5-ethanamine
1qft
2-(1H-imidazol-4-yl)ethan-1-amine
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(3H-Imidazol-4-yl)ethylamine
2-(3H-Imidazol-4-yl)-ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-imidazolyl)ethylamine
2-(4-Imidazolyl)ethylamine
2-[4-Imidazolyl]ethylamine
2-Imidazol-4-ylethylamine
2-Imidazol-4-yl-ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-imidazoleethylamine
4-Imidazoleethylamine
51-45-6
53290_FLUKA
5-imidazoleethylamine
5-Imidazoleethylamine
64422-25-9
924364-91-0
AC-13185
AC1L19ZT
AC1Q54BV
AC1Q54BW
AKOS000274386
ALBB-005968
BCBcMAP01_000250
beta-aminoethylglyoxaline
beta-Aminoethylglyoxaline
beta-aminoethylimidazole
beta-Aminoethylimidazole
beta-aminothethylglyoxaline
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
b-Imidazolyl-4-ethylamine
Bio1_000487
Bio1_000976
Bio1_001465
Bio2_000389
Bio2_000869
bmse000744
BSPBio_001117
BSPBio_002124
C00388
CCRIS 6535
CHEBI:18295
CHEMBL90
CID774
D08040
DivK1c_000308
EINECS 200-100-6
Eramin
Ergamine
Ergotidine
F411C768-A159-4FC0-A195-291A08BB03AA
Free histamine
H7125_SIGMA
histamine
|
Histamine
Histamine (DCF)
Histamine [USAN]
Histamine Base
Histamine, Free Base
Histaminum
Histaminum (TN)
HMS1362G19
HMS1792G19
HMS1990G19
HSDB 3338
HSM
IDI1_000308
IDI1_002144
Imidazole-4-ethylamine
Istamina
Istamina [Italian]
KBio1_000308
KBio2_000457
KBio2_001325
KBio2_003025
KBio2_003893
KBio2_005593
KBio2_006461
KBio3_000853
KBio3_000854
KBio3_001344
KBioGR_000457
KBioGR_001580
KBioSS_000457
KBioSS_001325
L000292
L-histamine
Lopac0_000595
Lopac-H-7250
LS-75835
MLS000069447
MolPort-001-785-597
MolPort-002-042-264
NCGC00015513-01
NCGC00015513-08
NCGC00093371-02
NCGC00093371-03
NCGC00093371-04
NCGC00093371-05
nchembio.87-comp54
nchembio714-comp1
NINDS_000308
NSC 33792
NSC33792
SDCCGMLS-0066601.P001
SMP1_000151
SMR000059091
SPBio_000729
Spectrum_000845
Spectrum2_000665
Spectrum3_000452
Spectrum4_000960
Spectrum5_000796
ST073926
STK346752
STOCK5S-55669
Theramine
UNII-820484N8I3
WLN: T5M CNJ D2Z
ZERO/004089
β-Imidazolyl-4-ethylamine
|
|
5 |
|
Meclizine |
Approved |
Phase 4 |
|
569-65-3 |
4034 |
Synonyms:
(+-)-Meclizine
1-((4-Chlorophenyl)phenylmethyl)-4-((3-methylphenyl)methyl)piperazine
1-(p-Chloro-.alpha.-phenylbenzyl)-4-(m-methylbenzyl)piperazine
1-(p-Chloro-alpha-phenylbenzyl)-4-(m-methylbenzyl)piperazine
1-(p-Chlorobenzhydryl)-4-(m-methylbenzyl)diethylenediamine
1-(p-Chlorobenzhydryl)-4-(m-methylbenzyl)piperazine
1-[(4-chlorophenyl)(phenyl)methyl]-4-[(3-methylphenyl)methyl]piperazine
1-[(4-chlorophenyl)-phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine
1104-22-9 (di-hydrochloride)
1-p-Chlorobenzhydryl-4-m-methylbenzylpiperazine
36236-67-6 (hydrochloride)
569-65-3
AB00053493
AC1L1H9K
AC1Q2IO5
Agyrax
Ancolan
Ancolon
Antivert
Antivert/25
Antivert/50
Bonadettes
Bonadoxin
Bonamine
Bonine
BPBio1_000588
BRD-A50311610-300-05-4
BRN 0332002
BSPBio_000534
BSPBio_001949
C07116
C25H27ClN2
Calmonal
CHEMBL1623
Chiclida
CID4034
D Vert
D08163
DB00737
Diadril
Dihydrochloride, meclizine
DivK1c_000407
Dramamine
Dramamine II
DVert
D-Vert
EINECS 209-323-3
Histamethine
Histamethizine
Histametizine
Histametizyn
Histametizyne
HSDB 3113
Hydrochloride, meclizine
IDI1_000407
Itinerol
KBio1_000407
KBio2_001371
KBio2_003939
KBio2_006507
KBio3_001449
KBioGR_000473
KBioSS_001371
L001136
LS-111206
Marex
Meclicot
meclizine
Meclizine
|
Meclizine [INN:BAN]
Meclizine dihydrochloride
Meclizine Hcl
Meclizine hydrochloride
Meclizine monohydrochloride
Meclozina
Meclozina [INN-Spanish]
Meclozine
Meclozine (BAN)
Meclozinum
Meclozinum [INN-Latin]
Medivert
MolPort-002-069-043
Monamine
Monohydrochloride, meclizine
Navicalm
Neo-istafene
Neo-Istafene
Neo-suprimal
Neo-Suprimal
Neo-suprimel
Neo-Suprimel
Nevidoxine
Nevidoxine (TN)
NINDS_000407
NSC 169189
NSC169189
Parachloramine
Peremesin
Pfizer brand 1 OF meclizine dihydrochloride
Pfizer brand 2 OF meclizine dihydrochloride
Pfizer consumer healthcare brand OF meclizine dihydrochloride
Postafene
Prestwick0_000457
Prestwick1_000457
Prestwick2_000457
Prestwick3_000457
Ravelon
Roberts brand OF meclizine dihydrochloride
Ru vert m
Ru-vert-m
RuVertM
Ru-Vert-M
Sabari
Sea-Legs
Siguran
SPBio_000100
SPBio_002473
Spectrum_000891
Spectrum2_000110
Spectrum3_000485
Spectrum4_000037
Spectrum5_000919
Subari
Suprimal
Torrens brand OF meclizine dihydrochloride
Travelon
U. C. B. 5062
U.C.B. 5062
UCB 170
UCB 5052
UCB 5062
UNII-3L5TQ84570
Vedim brand OF meclizine dihydrochloride
Veritab
Vomisseis
Vomissels
WLN: T6N DNTJ AYR&R DG& D1R C1
|
|
6 |
|
Hypnotics and Sedatives |
|
Phase 4 |
|
|
|
7 |
|
Dermatologic Agents |
|
Phase 4 |
|
|
|
8 |
|
Anesthetics, Local |
|
Phase 4 |
|
|
|
9 |
|
Histamine Antagonists |
|
Phase 4 |
|
|
|
10 |
|
Histamine Phosphate |
|
Phase 4 |
|
51-74-1 |
65513 |
Synonyms:
1H-Imidazole-4-ethanamine, phosphate (1:2)
2-Imidazol-4-ylethylamine orthophosphoric acid (1:2)
4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)
4-(2-Aminoethyl)imidazole di-acid phosphate
4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate
51-74-1
53623-99-7
74-56-6
AC1L23E4
CID65513
D04445
DB00667
EINECS 200-118-4
|
H0147
Histamine acid phosphate
Histamine biphosphate
Histamine dihydrogen phosphate
Histamine diphosphate
Histamine phosphate (1:2)
Histamine phosphate (TN)
Histamine phosphate (USP)
Histamine phosphate [USP]
Histamine positive
LS-78569
UNII-QWB37T4WZZ
|
|
11 |
|
Anti-Allergic Agents |
|
Phase 4 |
|
|
|
12 |
|
Histamine H1 Antagonists |
|
Phase 4 |
|
|
|
13 |
|
Scopolamine |
Approved, Investigational |
Phase 2, Phase 3 |
|
51-34-3, 6533-68-2 |
5184 |
Synonyms:
(-)-hyoscine
(-)-Hyoscine
(-)-Hyoscine hydrobromide
(-)-scopolamine
(-)-Scopolamine
(-)-Scopolamine bromide
(-)-Scopolamine hydrobromide
(-)-Scopolamine hydrobromide trihydrate
(+)-Hyoscine
(+)-Scopolamine
(1S,3S,5R,6R,7S)-6,7-epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate
(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate
(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoic acid
114-49-8
138-12-5
14797-94-5
1alphaH,5alphaH-Tropan-3alpha-ol, 6beta,7beta-epo
1alphaH,5alphaH-Tropan-3alpha-ol, 6beta,7beta-epoxy-, (-)-tropate (ester)
226562-00-1
28901-63-5
3-Oxa-9-azatricyclo(3.3.1.0(sup 2,4))nonan-7-ol, 9-methyl-, tropate (ester)
3-Oxa-9-azatricyclo(3.3.1.O(sup 2,4))nonan-7-ol, 9-methyl-, tropate (ester)
51-34-3
58670-87-4
6,7-Epoxytropine tropate
6,7-Epoxytropine tropic acid
65319-33-7
6-b,7-b-Epoxy-3-a-tropanyl S-(-)-tropate
6-b,7-b-Epoxy-3-a-tropanyl S-(-)-tropic acid
6beta,7beta-Epoxy-1alpha,5alpha-tropan-3alpha-ol
6beta,7beta-Epoxy-3alpha-tropanyl S-(-)-tropate
6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate
6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropic acid
6-Β,7-β-epoxy-3-α-tropanyl S-(-)-tropate
6-Β,7-β-epoxy-3-α-tropanyl S-(-)-tropic acid
81D34684-E0B2-4B3A-A36C-FB916BBC90F7
97991-84-9
9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]non-7-yl tropate
a-(Hydroxymethyl)benzeneacetate 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester
a-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester
AB00429689
AC1L1JSC
AC1L1L6Q
AC1L4A4J
AC1L9P7Q
AC1L9QO2
AC1LCW6T
AC1LDRGW
AC1MC3SI
AC1MHD40
AC1MIXH6
AC1MMY38
AC1Q60XM
AC-968
AKOS001581155
alpha-(Hydroxymethyl)benzeneacetate 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester
alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester
AR-1J2195
Atrochin
Atroquin
Atroscine
Atroscine Hydrobromide
Beldavrin
BPBio1_001049
BRD-A14566392-004-03-5
BRD-K89923877-003-02-4
BSPBio_000953
Buscopan
C01851
CAS-55-16-3
CHEBI:111434
CHEBI:16794
CHEMBL1201069
CHEMBL253569
CHEMBL608810
CID10017965
CID10267079
CID10267087
CID11968014
CID153311
CID2723877
CID3000322
CID3081743
CID3246242
CID450840
CID452977
CID5184
CID5702114
CID5809
CID6325382
CID638340
CID6432494
CID6451257
CID6604698
CID6713754
CID673473
CID9808333
CID9916237
D00138
DB00747
DivK1c_000291
EINECS 200-090-3
Epoxytropine tropate
Euscopol
HMS2090N13
HSDB 4074
Hydroscine hydrobromide
Hyocine F hydrobromide
|
Hyosceine
Hyoscine
Hyoscine bromide
Hyoscine hydrobromide
Hyoscyine hydrobromide
Hyosol
Hysco
IDI1_000291
Isopto hyoscine
Isopto Hyoscine
Isoscopil
KBio1_000291
KBio2_001430
KBio2_003998
KBio2_006566
KBio3_001814
KBioGR_001423
KBioGR_001853
KBioSS_001430
Kwells
L001096
l-Hyoscine hydrobromide
L-Hyoscine hydrobromide
Lopac0_001076
Lopac-S-1875
LS-144659
LS-144660
LS-194418
l-Scopolamine
L-Scopolamine-hydrobromide
Methscopolamine bromide
MLS000758270
MOLI001381
MolPort-002-052-054
MolPort-002-506-902
MolPort-005-938-576
NCGC00013722
NCGC00015932-01
NCGC00015932-02
NCGC00016245-01
NCGC00024357-02
NCGC00024357-04
NCGC00024357-05
NCGC00096833-01
NCGC00162334-01
NCGC00162334-02
nchembio.78-comp19
NCI60_005415
NCI61806
NINDS_000291
Norhyoscine
NSC-61806
Oscine
Pamine
Prestwick0_000877
Prestwick1_000877
Prestwick2_000877
Prestwick3_000877
S-(-)-Tropate
Scop
Scopamin
scopine (-)-tropate
scopine (−)-tropate
Scopine (-)-tropate
Scopine (-)-tropic acid
Scopine tropate
Scopoderm-TTS
scopolamine
Scopolamine (INN)
Scopolamine bromide
SCOPOLAMINE BROMIDE
Scopolamine hydrobromide
Scopolamine Hyoscine
Scopolaminhydrobromid
Scopolaminium bromide
Scopolammonium bromide
Scopos
SDCCGMLS-0066589.P001
SEE
Sereen
Skopolamin
SMP1_000270
SMR000449327
SPBio_001405
SPBio_002874
Spectrum_000950
Spectrum2_001313
Spectrum3_000897
Spectrum4_000992
Spectrum4_001187
Spectrum5_001142
Tocris-1414
Tranaxine
Transcop
Transderm scop
Transderm scop (TN)
Transderm-scop
Transderm-Scop
Transderm-V
Triptone
Tropane alkaloid
Tropic acid, 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(sup 2,4))non-7-yl ester
Tropic acid, ester with scopine
UNII-DL48G20X8X
xy-, (-)-tropate (ester)
ZINC19796020
Α-(hydroxymethyl)benzeneacetate 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester
Α-(hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester
|
|
14 |
|
Gastrointestinal Agents |
|
Phase 2, Phase 3 |
|
|
|
15 |
|
Neurotransmitter Agents |
|
Phase 2, Phase 3 |
|
|
|
16 |
|
Antiemetics |
|
Phase 2, Phase 3 |
|
|
|
17 |
|
Anesthetics |
|
Phase 2, Phase 3 |
|
|
|
18 |
|
Cholinergic Antagonists |
|
Phase 2, Phase 3 |
|
|
|
19 |
|
Mydriatics |
|
Phase 2, Phase 3 |
|
|
|
20 |
|
Muscarinic Antagonists |
|
Phase 2, Phase 3 |
|
|
|
21 |
|
Butylscopolammonium Bromide |
|
Phase 2, Phase 3 |
|
|
|
22 |
|
Cholinergic Agents |
|
Phase 2, Phase 3 |
|
|
|
23 |
|
Parasympatholytics |
|
Phase 2, Phase 3 |
|
|
|
24 |
|
Bromides |
|
Phase 2, Phase 3 |
|
|
|
25 |
|
Morphine |
Approved, Investigational |
|
|
57-27-2 |
5288826 |
Synonyms:
(-)(5.alpha.,6.alpha.)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(-)-Heroin hydrochloride
(−)-morphine
(-)-Morphine
(-)Morphine sulfate
(5a,6a)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5a,6a)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5alpha,6alpha)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5R,6S,9R,13S,14R)-4,5-epoxy-N-methyl-7-morphinen-3,6-diol
(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol
(5α,6α)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5Α,6α)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5α,6α)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5Α,6α)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol
(7R,7AS,12BS)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol
(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL
17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol
4,5alpha-Epoxy-17-methyl-7-morphinen-3,6alpha-diol
47106-99-0
4-methyl-(13R,14S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol
57-27-2
6211-15-0 (sulfate (2:1) (salt) pentahydrate)
64-31-3
64-31-3 (sulfate (2:1) (salt) anhydrous)
7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol
8053-16-5
85201-37-2
Anhydrous morphine
Apokyn
Astramorph PF
Avinza
BIDD:GT0147
C01516
CCRIS 5762
CHEBI:17303
CHEMBL70
Chloride, morphine
CID5288826
Contin, MS
Cube juice
D-(-)-Morphine
DB00295
DEA No. 9300
Depodur
DepoDur
Diacetylmorphine hydrochloride
Diamorphine hydrochloride
Dolcontin
Dreamer
Dulcontin
Duramorph
Duramorph PF
Duromorph
EINECS 200-320-2
Epimorph
Hard stuff
Heroin hydrochloride
Heroine hydrochloride
Hocus
HSDB 2134
|
Infumorph
Kadian
l-Morphine
LS-91748
M.O.S
Meconium
M-Eslon
MOI
MolPort-003-849-273
Morfina
Morfina [Italian]
Morfina dosa
Morphia
Morphin
Morphin [German]
Morphina
Morphina [Italian]
morphine
Morphine
Morphine [BAN]
Morphine chloride
Morphine Extra-Forte
Morphine Forte
Morphine H.P
Morphine sulfate
Morphine Sulfate
MORPHINE SULFATE
Morphine sulfate (2:1), anhydrous
Morphine sulfate (2:1), pentahydrate
MORPHINE, (5A,6A)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINIAN-3,6-DIOL, MORPHIUM, MORPHIA, DOLCONTIN, DUROMORPH, MORPHINA, NEPENTHE
Morphinism
Morphinum
Morphitec
Morphium
Morpho
Moscontin
Ms Contin
MS Contin
Ms Emma
MS/L
MS/S
MSIR
nchembio.317-comp1
nchembio.64-comp1
Nepenthe
NSC11441
O,O'-Diacetylmorphine hydrochloride
OMS Concentrate
Oramorph SR
Ospalivina
Rescudose
RMS
RMS Uniserts
Roxanol
Roxanol 100
Roxanol UD
SDZ 202-250
SDZ202-250
Statex
Statex Drops
Statex SR
Substitol
Sulfate, morphine
UNII-76I7G6D29C
Unkie
|
|
26 |
|
Rizatriptan |
Approved |
|
|
144034-80-0, 145202-66-0 |
5078 |
Synonyms:
144034-80-0
AC-1712
AC1L1JK9
BIDD:GT0361
C093622
CHEBI:48273
CHEMBL905
CID5078
D08485
DB00953
I06-2272
L000812
LS-83053
Maxalt
MK 462 free base
MK 462 Free base
MolPort-003-666-600
N,N-Dimethyl-2-(5-(1,2,4-triazol-1-ylmethyl)-1H-indole-3-yl)ethylamine
N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine
|
N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine
N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine
N,N-dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine
N,N-Dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine
N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine
NCGC00095899-01
Risatriptan
rizatriptan
Rizatriptan
Rizatriptán
Rizatriptan (INN)
Rizatriptan [INN:BAN]
Rizatriptan benzoat
Rizatriptan benzoate
rizatriptanum
Rizatriptanum
SPECTRUM1505189
TL8000966
UNII-51086HBW8G
|
|
27 |
|
tannic acid |
Approved |
|
|
1401-55-4 |
|
Synonyms:
ácido tánico
Gallotannic acid
|
|
|
28 |
|
Benzocaine |
Approved, Investigational |
|
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-aminobenzoic acid ethyl ester
4-amino-benzoic acid ethyl ester
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
Acetate, benzocaine
Acetate, Benzocaine
AE-562/40377256
Aethoform
Aethylium paraminobenzoicum
AI3-02081
AKOS000119763
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
AR-1H9065
Baby anbesol
Baby Anbesol
BB_SC-0019
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
benzocaine
Benzocaine
Benzocaine (USP/INN)
Benzocaine [INN:BAN]
Benzocaine acetate
Benzocaine Acetate
Benzocaine formate
Benzocaine Formate
Benzocaine hydrobromide
Benzocaine Hydrobromide
Benzocaine hydrochloride
Benzocaine Hydrochloride
Benzocaine methanesulfonate
Benzocaine Methanesulfonate
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
C07527
CAS-94-09-7
Caswell No. 430A
CHEBI:116735
CHEMBL278172
Chloraseptic
CID2337
D001566
D00552
DB01086
Dermoplast
Diet ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl PABA
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
ethylaminobenzoate-4
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
ETHYL-P-AMINOBENZOATE
Formate, benzocaine
Formate, Benzocaine
h-4-abz-oet
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, benzocaine
Hydrobromide, Benzocaine
Hydrochloride, benzocaine
Hydrochloride, Benzocaine
I05-0204
Identhesin
IDI1_000932
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
Methanesulfonate, benzocaine
Methanesulfonate, Benzocaine
MLS001331704
MLS002153970
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
nchembio.182-comp4
NINDS_000932
Norcain
Norcaine
Norcainum
NSC 122792
NSC 41531
NSC41531
NSC4688
Oprea1_750694
Oprea1_827402
Orabase-b
Ora-jel
Orthesin
Otocain
Outgro
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
Parathesin
Parathesin (TN)
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Prestwick_991
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Slim mint gum
SMR000059025
Solarcaine
Solu H
SPBio_000134
SPBio_002844
Spectrum_000074
SPECTRUM1500139
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
STK043620
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
|
|
29 |
|
Physostigmine |
Approved, Investigational |
Early Phase 1 |
|
57-47-6 |
5983 |
Synonyms:
(-)-physostigmine
(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate
(3aS-cis)-1,2,3,3a,8,8a-Hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-ol methylcarbamate (ester)
[(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate
1,2,3,3abeta,8abeta-Hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)-indol-5-yl methylcarbamate
45710_FLUKA
50975-37-6
511-49-9
57-47-6
AC-15983
AC1L1LJL
ACon1_000097
Antilirium
BPBio1_000388
BRD-K25650355-001-02-5
BRD-K25650355-059-02-3
BSPBio_000352
BSPBio_002189
C06535
Calabarine
Carbamic acid, methyl-, ester with eseroline
CCRIS 3422
CHEBI:27953
CHEMBL94
CID5983
CPD-12048
CS 58525
D00196
D010830
DB00981
DivK1c_006477
E 8375
E8375_SIGMA
EINECS 200-332-8
Erserine
Eserine
Eserine (TN)
Eserine sulfate
Eserolein, methylcarbamate
Eserolein, methylcarbamate (ester)
Esromiotin
EU-0100483
Ezerin
Fysostigmin
Fysostigmin [Czech]
HMS1921G06
HMS2089M11
HSDB 3161
KBio1_001421
KBio2_001396
KBio2_002278
KBio2_003964
KBio2_004846
KBio2_006532
KBio2_007414
KBio3_001689
KBio3_001842
KBioGR_001433
|
KBioGR_002061
KBioGR_002533
KBioSS_001396
KBioSS_002279
Lopac0_000483
LS-109562
MCV 4484
MEGxp0_001872
Methyl-carbamic acid, ester with eseroline
MLS001304022
MolPort-001-683-926
NCGC00093889-01
NCGC00093889-02
NCGC00093889-03
NCGC00093889-04
NCGC00093889-05
NCGC00093889-06
NCGC00093889-08
NIH 10421
NSC 30782
NSC30782
P0406
physostigmine
Physostigmine
Physostigmine (USP)
Physostigmine [USAN:BAN]
Physostol
Prestwick0_000566
Prestwick1_000566
Prestwick2_000566
Prestwick3_000566
Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)
RCRA waste no. P204
SDCCGMLS-0066585.P001
SMR000718753
SPBio_000339
SPBio_000774
SPBio_001285
SPBio_002571
SpecPlus_000381
Spectrum_000916
Spectrum_001789
SPECTRUM1500753
Spectrum2_000330
Spectrum2_000757
Spectrum2_001283
Spectrum3_000545
Spectrum3_000901
Spectrum4_000997
Spectrum4_001631
Spectrum4_001913
Spectrum5_000441
Spectrum5_000626
Spectrum5_001672
STOCK1N-03554
UNII-9U1VM840SP
WLN: T B556 EN GNTT&J B1 E1 G1 KOVM1
|
|
30 |
|
Serotonin 5-HT1 Receptor Agonists |
|
|
|
|
|
31 |
|
Serotonin Receptor Agonists |
|
|
|
|
|
32 |
|
Anti-Inflammatory Agents |
|
Early Phase 1 |
|
|
|
33 |
|
Analgesics, Non-Narcotic |
|
Early Phase 1 |
|
|
|
34 |
|
Cyclooxygenase Inhibitors |
|
Early Phase 1 |
|
|
|
35 |
|
Salicylates |
|
Early Phase 1 |
|
|
|
36 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Early Phase 1 |
|
|
|
37 |
|
Antirheumatic Agents |
|
Early Phase 1 |
|
|
|
38 |
|
Analgesics |
|
Early Phase 1 |
|
|
|
39 |
|
Glycopyrrolate |
|
Early Phase 1 |
|
596-51-0 |
3494 |
Synonyms:
(1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate
(1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate bromide
.beta.-1-Methyl-3-pyrrolidyl-.alpha.-cyclopentylmandelate methobromide
1,1-Dimethyl-3-hydroxypyrrolidinium bromide .alpha.-cyclopentylmandelate
1,1-Dimethyl-3-hydroxypyrrolidinium bromide alpha-cyclopentylmandelate
1-Methyl-3-pyrrolidinyl .alpha.-phenylcyclopentaneglycolate methobromide
1-Methyl-3-pyrrolidyl alpha-phenylcyclopentaneglycolate methobromide
3-(erythro-2-Cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidiniumbromid
3-Hydroxy-1,1-dimethylpyrrolidinium bromide .alpha.-cyclopentylmandelate
3-Hydroxy-1,1-dimethylpyrrolidinium bromide alpha-cyclopentylmandelate
3-Hydroxy-1,1-dimethylpyrrolidinium bromide-.alpha.-cyclopentylmandelate
53808-86-9
596-51-0
AB00513912
AC-15990
AC1L1G28
AC1L1XX0
AC1LAW54
AC1Q1RGS
AC1Q60WT
AD-237
AHR 504
AHR-504
AR-1J1255
Asecryl
BPBio1_000806
Bromide, glycopyrronium
Bromure de glycopyrronium
Bromure de glycopyrronium [INN-French]
Bromure de ritropirronio
Bromure de ritropirronium
Bromuro de glicopirronio
Bromuro de glicopirronio [INN-Spanish]
BSPBio_000732
C19H28NO3
CHEMBL1201027
CHEMBL1201335
CID11693
CID3494
CID521843
Copyrrolate
CPD000469282
Cuvposa
D00540
DB00986
EINECS 209-887-0
Gastrodyn
Glycopyrrolate
GLYCOPYRROLATE
Glycopyrrolate (USP)
Glycopyrrolate [USAN]
Glycopyrrolate bromide
Glycopyrrolic acid
Glycopyrroni bromidum
|
Glycopyrronii bromidum
Glycopyrronii bromidum [INN-Latin]
Glycopyrronium
glycopyrronium bromide
Glycopyrronium bromide
Glycopyrronium bromide (JAN/INN)
HMS1570E14
HMS2051P12
HMS2094A05
I14-3643
L001045
LS-138344
Mandelic acid, .alpha.-cyclopentyl-, ester with 3-hydroxy-1,1-dimethylpyrrolidinium bromide
MLS001424112
MLS002222301
MolPort-002-885-831
NCGC00179456-01
Nodapton
NSC 250836
NSC 251251
NSC 251252
NSC250836
NSC251251
NSC251252
NVA 237
NVA-237
Prestwick0_000746
Prestwick1_000746
Prestwick2_000746
Prestwick3_000746
PT-001
Pyrrolidinium, 1,1-dimethyl-3-hydroxy-, bromide, alpha-cyclopentylmandelate
Pyrrolidinium, 3-((cyclopentylhydroxyphenylacetyl)oxy)-1,1-dimethyl-, bromide
Pyrrolidinium, 3-[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethyl-, bromide
Pyrrolidinium, 3-hydroxy-1,1-dimethyl-, bromide, .alpha.-cyclopentylmandelate
Pyrrolidinium, 3-hydroxy-1,1-dimethyl-, bromide, alpha-cyclopentylmandelate
Pyrrolidinium, 3-hydroxy-1,1-dimethyl-, bromide, alpha-cyclopentylmandelate (8CI)
Ritropirronium bromide
Ritropirronium bromide [INN]
Robanul
Robinal
Robinul
Robinul (TN)
ROBINUL FORTE
Salt*)
SAM001246629
SAM002589987
SMR000469282
SPBio_002671
ST51054976
Tarodyl
Tarodyn
UNII-V92SO9WP2I
WLN: T5KTJ A1 A1 COVXQR&- AL5TJ &Q &E
|
|
40 |
|
Cholinesterase Inhibitors |
|
Early Phase 1 |
|
|
|
41 |
|
Serotonin |
Investigational, Nutraceutical |
|
|
50-67-9 |
5202 |
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5 Hydroxytryptamine
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
5-Hydroxy-tryptamine
Antemovis
|
DS Substance
Enteramin
Enteramine
Hippophaine
Hydroxytryptamine
Serotonine
sérotonine
thrombocytin
Thrombocytin
thrombotonin
Thrombotonin
|
|
Interventional clinical trials:
(show all 32)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Motion Sickness Medications and Vestibular Time Constant |
Unknown status |
NCT03270839 |
Phase 4 |
Bonine 25Mg Chewable Tablet;Kwells;Placebo Oral Tablet |
2 |
Countermeasures to Reduce Sensorimotor Impairment and Space Motion Sickness Resulting From Altered Gravity Levels |
Completed |
NCT02136420 |
Phase 4 |
Promethazine;Placebo |
3 |
Clinical Evaluation of the Use of Ginger Extract in the Management of Motion Sickness |
Completed |
NCT03755596 |
Phase 4 |
Z. officinale extract |
4 |
Meclizine Plasma Levels in Responders and Non-responders |
Not yet recruiting |
NCT04482985 |
Phase 4 |
Meclizine Hydrochloride |
5 |
A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of the Safety, Efficacy and Pharmacokinetics of DPI-386 Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness |
Completed |
NCT04184115 |
Phase 3 |
DPI-386 Nasal Gel;Placebos |
6 |
A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of the Safety and Efficacy of DPI-386 Nasal Gel on Ocean Going Vessels for the Prevention and Treatment of Nausea Associated With Motion Sickness |
Completed |
NCT03986905 |
Phase 3 |
Scopolamine Nasal Gel |
7 |
Motion Syros: A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy of Tradipitant in the Treatment of Motion Sickness |
Recruiting |
NCT04327661 |
Phase 3 |
Tradipitant High Dose;Tradipitant Low Dose;Placebo |
8 |
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Safety and Efficacy of DPI-386 Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion Sickness |
Recruiting |
NCT04272255 |
Phase 3 |
scopolamine HBr;Transdermal Scopolamine |
9 |
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Safety, Efficacy and Pharmacokinetics of DPI-386 Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects With Open-Label Follow-Up |
Recruiting |
NCT03988530 |
Phase 3 |
Scopolamine |
10 |
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Safety and Efficacy of Defender Pharmaceuticals Inc, (DPI)-386 Nasal Gel on Ocean-Going Vessels for the Prevention and Treatment of Nausea Associated With Motion Sickness |
Recruiting |
NCT03920644 |
Phase 3 |
Scopolamine Transdermal Patch [Transderm Scop];Scopolamine;Placebo Patch;Placebo Gel |
11 |
Pharmacokinetic and Efficacy Profile of Low-Dose Intranasal Scopolamine Spray for Motion Sickness |
Terminated |
NCT02155309 |
Phase 2, Phase 3 |
Scopolamine;Placebo |
12 |
A Randomized, Double-Blind Placebo-Controlled Phase 3 Study of the Safety, Pharmacokinetics, and Efficacy of DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness |
Terminated |
NCT04219982 |
Phase 2, Phase 3 |
DPI-386 Nasal Gel;DPI-386 Placebo Nasal Gel;Transderm Scop® |
13 |
Levo Phencynonate Hydrochloridefor the Prevention of Motion Sickness (Seasickness): a Randomized, Double-blind, Placebo Controlled, Multicenter,Phaseâ…¡Clinical Study |
Completed |
NCT02241629 |
Phase 2 |
placebo;levo phencynonate hydrochloride |
14 |
Effects of Transdermal Scopolamine on Occupational Performance |
Completed |
NCT00374478 |
Phase 2 |
Scopolamine |
15 |
Motion Sifnos: A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness |
Completed |
NCT03772340 |
Phase 2 |
Tradipitant;Placebo |
16 |
A Randomized, Single-center, Crossover, Comparative Bioavailability and Adhesion Performance Study, Comparing Single Administrations of a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants. |
Completed |
NCT02839135 |
Phase 1 |
Reformulated scopolamine patch;Marketed scopolamine patch |
17 |
Evaluation and Characterization of Motion Sickness on Passengers Sailing on the Astrolabe |
Unknown status |
NCT02911402 |
|
|
18 |
Virtual Reality Stress and Relief Project, Research on Quantification of VR Related Stress, Motion Sickness and Visual Fatigue |
Unknown status |
NCT02986555 |
|
|
19 |
Risk Factors for Nausea, Vomiting and Pruritus After Neuraxial Morphine for Cesarean Section |
Unknown status |
NCT03178058 |
|
|
20 |
Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy Volunteers |
Completed |
NCT02177890 |
|
|
21 |
Effect of Rizatriptan on Rotational Motion Sickness in Migraineurs |
Completed |
NCT00360282 |
|
Rizatriptan |
22 |
A Pilot Study to Assess the Feasibility and the Preliminary Efficacy of a Virtual Reality Distraction Intervention for Pain Management and Anxiety in Children With Burn Injuries During Hydrotherapy |
Completed |
NCT02794103 |
|
|
23 |
Comparison of the Therapeutic Effect of Acupressure Therapy and Iberogast ® (STW-5) in Children With Functional Nausea - a Randomized Clinical Trial With Sham-conditions |
Completed |
NCT02660970 |
|
Iberogast |
24 |
Virtual Reality in Labor and Delivery for Reduction in Pain |
Recruiting |
NCT03437031 |
|
|
25 |
INtervention for Cognitive Reserve Enhancement in Delaying the Onset of Alzheimer's Symptomatic Expression: The INCREASE Study |
Active, not recruiting |
NCT02849639 |
Early Phase 1 |
Scopolamine patch |
26 |
Temporal Synthesis of Vestibular and Extra-Vestibular Sensory Signals |
Enrolling by invitation |
NCT04196933 |
|
|
27 |
Sensory Re-weighting Training for Orientation and Equilibrium: A Pilot Trial for the Treatment of Visually-induced Dizziness |
Not yet recruiting |
NCT04331561 |
|
|
28 |
High-precision Immersive Robotic Environment for Sensorimotor Training |
Not yet recruiting |
NCT04420949 |
|
|
29 |
Toward a Computationally-Informed, Personalized Treatment for Hallucinations |
Not yet recruiting |
NCT04366518 |
Early Phase 1 |
Physostigmine Salicylate;Scopolamine |
30 |
Virtual Reality MObility for Burn Patients (VR-MOBILE): A Pilot Randomized Clinical Trial |
Not yet recruiting |
NCT04538573 |
|
Standard Treatment |
31 |
Nano-X Image Guidance: CBCT With Gravity-induced Motion |
Not yet recruiting |
NCT04488224 |
Early Phase 1 |
|
32 |
Effects of Vertical Prism on the Symptoms of Dizziness, Headache and Anxiety as Caused by Vertical Heterophoria: A Randomized, Double-blinded, Placebo-controlled, Cross-over Study |
Terminated |
NCT00785135 |
|
|
Inferred drug relations via
UMLS
71
/
NDF-RT
51
:
bromodiphenhydramine
Bromodiphenhydramine hydrochloride
chlorcyclizine
Chlorcyclizine hydrochloride
Dimenhydrinate
Diphenhydramine
Diphenhydramine Citrate
|
Diphenhydramine Hydrochloride
Meclizine
Meclizine Hydrochloride
Promethazine
PROMETHAZINE HYDROBROMIDE
Promethazine Hydrochloride
|
Cochrane evidence based reviews: motion sickness
|